logo
The Global Fund has just made history – now it must start a revolution

The Global Fund has just made history – now it must start a revolution

Mail & Guardian21-05-2025
HIV treatment has, for the first time, been made in Africa.
On 6 May 2025, a quiet revolution took place. The Global Fund to Fight Aids, Tuberculosis and Malaria announced it had, for the first time in its history,
For many outside Africa, this might seem like a footnote in global health procurement logistics. For us on the continent, it is nothing short of history. It's a symbolic and literal act of African solidarity, scientific excellence and economic assertion.
Africa is standing up and saying: 'We will no longer be the last in line for our own survival; we are the source of our own solutions.'
This is not just about pills in blister packs. It is about power, ownership and self-determination in a world where Africa has too often been positioned as a passive recipient of generosity rather than a co-architect of its future.
We are on the cusp of a new era, one where African science, African economies and African futures are not afterthoughts in the global health agenda, but drivers of it.
From political independence to pharmaceutical liberation
Sixty years after many African nations won political independence, the continent is still shackled in economic and technological dependency. Nowhere is this more apparent than in the pharmaceutical sector. Despite bearing the highest burden of HIV globally, Africa has historically relied on imports for between
More than 25 million Africans are living with HIV. Many rely on daily antiretroviral therapy to survive. Ensuring consistent, affordable and sovereign access to these treatments is not optional, it is urgent. But this moment also has implications beyond HIV. It can catalyse African manufacturing in drugs for TB, malaria and non-communicable diseases, vaccines and its pandemic preparedness.
The Global Fund's procurement is the first stone in what could be a continental avalanche of pharmaceutical innovation and a positive step towards the Africa Centres for Disease Control and Prevention's goal to produce 60% of vaccine needs domestically by 2040 through the
From an economic perspective, this move could reshape access to medicines. The benefits of local pharmaceutical production are well-documented but rarely supported at the scale required.
Jobs, cost savings and resilience to health shocks
When medicines are imported, African governments pay not only for the product but also for shipping, import duties and the often-exploitative pricing structures of external manufacturers. Local production, when scaled,
African manufacturers are more likely to understand the price sensitivities of their domestic markets, making them natural allies in the fight for affordable treatment.
When Africa produces at scale, we negotiate from strength. A diversified supply landscape
A robust pharmaceutical sector means more than factories, it means engineers, scientists, quality-assurance professionals, logisticians and educators. It builds a value chain that uplifts entire communities and redirects millions in procurement spend into local economies.
The ripple effect is massive: GDP growth, regional trade and reduced foreign currency outflows.
The Covid-19 pandemic exposed the fragility of international medical supply chains. African countries were left scrambling for vaccines, oxygen and personal protective equipment. By strengthening domestic pharmaceutical capacity, we insulate our public health systems from geopolitical shocks and ensure more consistent access to life-saving drugs.
Four steps to secure systemic change
This procurement cannot remain an isolated incident, a singular success trotted out at conferences and summits. It must spark a movement. A revolution in how global health actors approach access, equity and economic justice in Africa.
Here's what must happen next:
1. Global Fund must make local procurement a permanent policy.
The fund and other major donors, such as Unitaid, must make local sourcing of commodities a default, not a deviation. Pepfar (before Trump got hold of it) was leading the way, aiming for 70% of its funding to go to local partners, but medicines and vaccines were still largely imported.
Policies must be put in place to favour regional production when quality and cost-effectiveness are assured. The success in Kenya should lead to similar procurement from South Africa, Nigeria, Ghana and Senegal, all of which have growing pharmaceutical capabilities.
2. It is time for African governments to move from rhetoric to investment.
Local businesses cannot thrive without local demand. Tax incentives, infrastructure support and subsidies for research and development must be mobilised to grow local pharmaceutical industries. More importantly, governments must commit to procuring from African manufacturers, not only for export, but for national programmes.
3. Regional collaboration must replace national silos.
The African Medicines Agency, operated by the AU, must fast-track regional regulatory harmonisation. This will allow a medicine approved in one country to move freely across borders, removing duplication and accelerating access. A thriving continental pharmaceutical market is only possible if we dismantle bureaucratic barriers.
4. Civil society must hold all stakeholders accountable.
We, the people, cannot afford to be passive in this process. Civil society must monitor procurement decisions, expose backroom deals that favour multinationals and demand transparency in donor policies. Every dollar spent outside Africa, when there is a qualified African supplier is not just lost income, is a political betrayal
We are the generations of return
For centuries, Africa has been mined for its resources, such as gold, diamonds and rubber. Now, the world mines the continent for data, clinical-trial volunteers and intellectual labour. But we are the generations of return. We are bringing back sovereignty to our laboratories, dignity to our procurement systems and power to our people.
This procurement by the Global Fund must be remembered not just as the first time an African-made HIV treatment was purchased, but as the last time it was considered unusual.
It is the beginning of something long overdue — a health system made by us, for us, accountable to us. The symbolism is rich. The politics are radical. The economics are clear.
Let the rest of the world catch up.
Tian Johnson is the founder and strategist of the African Alliance, a pan-African health justice advocacy group.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health minister calls for bold action as TB vaccine nears reality
Health minister calls for bold action as TB vaccine nears reality

The Citizen

time7 hours ago

  • The Citizen

Health minister calls for bold action as TB vaccine nears reality

Minister of Health Dr Aaron Motsoaledi has stressed the urgent need for innovative solutions to combat tuberculosis (TB), a disease that has historically affected not only South Africa but countries around the world. 'We are here because we believe that TB – a disease that has shaped the history and health of our country and indeed, the whole world – can be ended. Not through words alone, but through action, partnership, and innovation,' he said on Thursday. The minister was delivering the keynote address at the country's TB Vaccine Preparedness Workshop in Johannesburg. The workshop aims to advance policy and decision-making for the introduction of TB vaccines. Protecting the most vulnerable Addressing policymakers, scientists and community leaders, Motsoaledi said the upcoming phase will introduce preventative TB vaccination measures, which will also support the fight against HIV and Aids. For over a century, South Africa has relied on the Bacille Calmette-Guérin vaccine to protect children from TB, but the minister pointed out that there has been no tool to protect adolescents and adults. 'These are the very groups most at risk of getting sick and transmitting TB,' he said. With several new TB vaccine candidates in the late stages of clinical trials, the most promising options are expected to be available in the next few years. The workshop positioned South Africa as one of the first countries ready to deliver a new generation of TB vaccines to the most vulnerable populations, including adolescents and adults. Ending 'slavery' of disease The minister expressed confidence that upcoming trials would yield positive results, potentially leading to a new vaccine for older age groups. TB remains a leading cause of death from infectious disease and a major contributor to poor health both locally and globally. 'Imagine the day when we announce the availability of the vaccine for tuberculosis,' he said, likening it to 'the day of true freedom from slavery' for those affected. Motsoaledi described the disease as a form of 'devastating slavery' that fuels poverty and premature death. 'South Africa is not waiting for the world to act. We are preparing – intentionally, early and inclusively.' Commitment to readiness The minister used the country's first national gathering on TB vaccine readiness to reaffirm South Africa's leadership in the global fight against TB and HIV. 'When South Africa wins against TB and HIV and Aids the world will win the war,' he said. He noted that throughout his tenure, he has sought to elevate TB on the global health agenda, recalling his 2018 address at the United Nations calling for world leaders to act. 'While global attention has often turned to emerging health threats, South Africa has remained focused on the enduring challenge of TB,' he said. He also acknowledged the devastating impact of TB on communities already battling HIV. Systems, trust and investment 'Today's discussions remind us that vaccine introduction is not just about science – it is about health systems. It is about trust. It is about readiness.' Motsoaledi emphasised the importance of preparing the health sector for the rollout, saying the agenda highlighted key areas such as evidence generation, delivery systems, and supply chain readiness. 'Investment in human life means everything,' he said, calling for strong financial backing and stakeholder support. He urged participants to build community trust and advocate for broad acceptance of the new vaccine. 'We must walk the path with our people,' he said. – Breaking news at your fingertips… Follow Caxton Network News on Facebook and join our WhatsApp channel. Nuus wat saakmaak. Volg Caxton Netwerk-nuus op Facebook en sluit aan by ons WhatsApp-kanaal. Read original story on

World Brain Day: More than 40% of dementia cases can be prevented
World Brain Day: More than 40% of dementia cases can be prevented

The Citizen

time15 hours ago

  • The Citizen

World Brain Day: More than 40% of dementia cases can be prevented

World Brain Day: More than 40% of dementia cases can be prevented The World Health Organization estimates that 57 million people globally live with dementia, with this number expected to reach 153 million by 2050. A total of 60% of people with dementia live in low- and middle-income countries, but this will rise to 71% by 2050. Welma Geldenhuys, senior social worker of the Association for Dementia and Alzheimer's of South Africa in Pretoria, said that for the association, World Brain Day is about creating awareness for communities and families of how to let people with dementia live lives of dignity and quality. 'At the association, this is something we truly advocate for,' said Geldenhuys. Overall, around 45% of cases of dementia are potentially preventable by addressing 14 modifiable risk factors at different stages during the life course. These include things such as not completing secondary education, social isolation, and depression, as well as several medical conditions such as hypertension, obesity and diabetes. 'We need to get the word out that it is important to get a professional diagnosis of the illness by an expert medical professional because the right treatment and medication can be administered,' explained Geldenhuys. Diet might also be an important aspect to look at in addition to these 14 factors, and has a key role in reducing the risk of chronic diseases that affect dementia risk. Speaking ahead of World Brain Day, Dr Patty Francis, president of the Neurological Association of South Africa, said dementia is no longer an inevitable consequence of old age, but 'the result of decades-long exposure to modifiable risk factors'. Dr Francis said the brain is highly sensitive to long-term physical, emotional, and environmental stressors. 'The rise in dementia in our region is deeply concerning, considering that we carry high burdens of HIV, hypertension, diabetes and stroke, all of which are linked to increased dementia risk,' she said. 'The most powerful message we can share this World Brain Day is that dementia is not just about ageing, it's about lifelong brain health. What we do in our 30s, 40s and 50s has a direct impact on our risk later in life.' Although addressing risk factors at an early stage of life is desirable, there is also a benefit from tackling risk throughout life; it is never too early or too late to reduce dementia risk. 'Dementia does not happen overnight. It often starts with decades of unmanaged risk factors such as high blood pressure, physical inactivity, obesity, smoking, poor sleep, alcohol abuse, and hearing loss, all of which silently damage brain tissue. When addressing these, research shows dementia could be prevented or delayed in up to four in 10 cases.' 'Every stage of life offers an opportunity to protect your brain,' said Dr Francis. 'From maternal nutrition to childhood immunisation, and from midlife stress management, to staying socially connected in older age. Preventions start early and are lifelong.' While dementia presents differently in each person, common warning signs include: – Memory loss that disrupts daily life – Difficulty performing familiar tasks – Language problems such as difficulty in speaking or writing – Confusion with time and place – Trouble understanding visual images – Misplacing things and losing the ability to retrace one's steps – Decreased or poor judgement – Personality or mood changes – Withdrawal from work or social activities – Problems with reasoning or problem-solving. Other red flags include trouble with planning and organising, poor co-ordination and control of movements, and confusion and disorientation. 'It's important not to dismiss symptoms as just getting older,' Dr Francis said. 'Even in younger adults, persistent cognitive changes should be assessed by a neurologist or specialist physician.' Some forms of dementia are amenable to therapy, such as HIV-related dementia or deficiency in vitamin B12. While there is currently no cure for Alzheimer's disease, early diagnosis and treatment can significantly slow progression and improve quality of life, with options, including: – Medication to manage cognitive symptoms and behaviour – Cognitive rehabilitation – Occupational therapy – Management of underlying conditions like hypertension or diabetes. Dr Francis said new drug developments, such as anti-amyloid therapies, are promising but remain costly and limited in availability in most low- and middle-income countries. 'In South Africa, our most urgent need is access to early screening and specialist care, particularly in under-resourced communities. 'We also need to destigmatise dementia, so families feel supported, rather than isolated,' she added. 'This World Brain Day, we are calling on all South Africans to prioritise brain health from the earliest stages of life. 'Healthy brains build healthy communities and the power to prevent dementia starts with awareness, education and action.' If you suspect someone you know is showing signs of dementia, you can get support and guidance from your local GP or community clinics for referral to specialists, or Alzheimer's South Africa. A workshop on dementia will be held on August 20 at the Sungardens Hospice in Lynnwood, Pretoria, by Alzheimer's South Africa from 09:00 to 13:00. More information is available from Welma Geldenhuys, who can be called on 082 821 4862, or visit the ADASA website on Do you have more information about the story? Please send us an email to [email protected] or phone us on 083 625 4114. For free breaking and community news, visit Rekord's websites: Rekord East For more news and interesting articles, like Rekord on Facebook, follow us on Twitter or Instagram or TikTok.

Motsoaledi urges innovation to end TB
Motsoaledi urges innovation to end TB

The Citizen

timea day ago

  • The Citizen

Motsoaledi urges innovation to end TB

Minister of Health, Dr Aaron Motsoaledi, has stressed the urgent need for innovative solutions to combat tuberculosis (TB), a disease that has historically affected not just South Africa but also countries around the world. 'We are here because we believe that TB – a disease that has shaped the history and health of our country and indeed, the whole world – can be ended. Not through words alone, but through action, partnership, and innovation,' he said on Thursday. The Minister was delivering a keynote address at the country's TB Vaccine Preparedness Workshop held in Johannesburg. The workshop is aimed at advancing policy and decision-making for the introduction of TB vaccines. Addressing policymakers, scientists and community leaders, Motsoaledi stated that the upcoming phase will introduce preventative TB vaccination measures, which will also enhance the ongoing fight against HIV and Aids. For over a century, South Africa has relied on the Bacille Calmette-Guérin (BCG) vaccine to protect its children from TB, but the Minister pointed out that there has been no tool that can protect adolescents and adults. 'These are the very groups most at risk of getting sick and transmitting TB.' With several new TB vaccine candidates in the late stages of clinical trials, the most promising options are expected to be available in the next few years. This workshop positioned the country as one of the first that is ready to deliver a new generation of TB vaccines to the most vulnerable populations, including adolescents and adults. The Minister expressed confidence that the upcoming clinical trials would yield positive results, potentially leading to a new vaccine for older age groups within the next few years. TB is a leading cause of death from an infectious disease and a major contributor to ill-health in South Africa and globally. 'Imagine the day when we announce the availability of the vaccine for tuberculosis,' he said, likening it to 'the day of true freedom from slavery' for those suffering from the disease. Motsoaledi described the disease as a form of 'devastating slavery' that exacerbates poverty and leads to premature death. 'South Africa is not waiting for the world to act. We are preparing – intentionally, early and inclusively.' The Minister has used the first national gathering dedicated to the TB vaccine readiness platform to reiterate South Africa's commitment to lead by example in the global fight against TB and HIV. 'When South Africa wins against TB and HIV and Aids the world will win the war,' he said. He told the attendees that through his tenure as Health Minister, he consistently sought to elevate the profile of TB on a global scale. Motsoaledi recalled his 2018 address at the United Nations, where he rallied for world leaders to commit to addressing the TB crisis. 'While global attention has often turned to emerging health threats, South Africa has remained focused on the enduring challenge of TB,' he said. He also acknowledged the disease's severe impact on communities already struggling with HIV. 'Today's discussions remind us that vaccine introduction is not just about science – it is about health systems. It is about trust. It is about readiness.' He also used the platform to emphasise the importance of preparing the health sector for the rollout of the TB vaccine. The agenda for the workshop highlighted key thematic areas crucial for readiness, including generating evidence for policy and investment, strengthening delivery systems for TB vaccines, and ensuring manufacturing and supply chain readiness. 'Investment in human life means everything,' he said, stressing the need for robust financial backing to ensure effective vaccine deployment. The Minister took the time to urge stakeholders to foster community trust and strong advocacy to ensure widespread acceptance of the TB vaccine upon its introduction. 'We must walk the path with our people,' he said. –

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store